Open Access Highly Accessed Email this article to a friend

Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group

Alexandra Peyser, Nathaniel MacHardy, Freya Tarapore, Jacqueline MacHardy, Leslie Powell, Debbie S Gipson, Virginia Savin, Cynthia Pan, Theresa Kump, Suzanne Vento and Howard Trachtman*

BMC Nephrology 2010, 11:2  doi:10.1186/1471-2369-11-2

Fields marked * are required

Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Nephrology's emails?